We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Novel Multiplexed Protein Sensor Developed

By LabMedica International staff writers
Posted on 14 Aug 2013
A novel method has been developed for parallel protein analysis that is, in principle, capable of identifying hundreds or even thousands of different proteins.

The device is able to identify the specific proteins in the fluid and allows rapid and reliable differentiation between harmless microorganisms and dangerous pathogens. More...


Chemists at Johannes Gutenberg University (Mainz, Germany) have designed a sensor that is only of one-tenth of a square millimeter in area, but capable of performing a hundred different individual tests on that surface. The 'test strips' consist of glass capillary tubes that have gold nanoparticles as sensor elements on their internal surfaces. The test involves placing a tiny drop of blood, saliva, or other bodily fluid on a small test strip, which is then placed in the device.

The scientists used the simple and direct principle of plasmons in noble metal nanoparticles, which react to protein binding by a shift of the resonance wavelength. This is the target detection method for both the mapped and the unmapped sensors by monitoring individual nanoparticles by optical dark-field spectroscopy. The team used four different target proteins to demonstrate the viability of the concept, its ability to detect concentrations in the nanomolar range, and the possibility to recycle the sensors for more than one analysis.

The four proteins tested were thrombin, immunoglobulin E (IgE), streptavidin, and fibronectin. When a protein docks with one of these special DNA strands, called aptamers, the corresponding nanoparticle changes its color. The color changes can be detected with the aid of a spectrometer. For this purpose, the capillary tubes are placed under a microscope designed, constructed, and provided with the necessary software by the team of chemists. Low-cost serial production of the sensors is feasible if advanced nanofabrication methods such as nanoprinting or optical trapping are used.

Christina Rosman, DiplChem, first author of the study, said, “We have demonstrated a new approach for a multiplexed assay that detects multiple proteins simultaneously by letting a fluid flow past the randomly positioned gold nanorods. We see the potential to extend our method to the simultaneous detection of hundreds or even thousands of different target substances." There are manifold possible applications of a test for multiple targets in a single procedure. The low-cost sensors could be directly used by physicians in their practices in order to detect and discriminate various types of influenza viruses with which their patients could be infected. The study was published on June 21, 2013, in the journal Nano Letters.

Related Links:

Johannes Gutenberg University



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.